Bharat Parenterals share news, announcements and annual reports
NSE: BPLPHARMABSE: 541096Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 29 Oct 2026. Previous close ₹1,912.90.
29 Oct: open ₹1,912.90, high ₹1,932.00, low ₹1,869.10
- Next results date: the board meets on 29 Oct 2026 to consider: quarterly results. Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,318 Cr1,597th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Owners' profit not stated
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 4.09
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.05%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −5.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.47
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 4,33268.7% delivered
Bharat Parenterals share news and announcements
385 announcements, routine notices left out, newest first. Page 3 of 8.
Nov 2024
8 Nov · Disclosure Under Regulation 7(2) Of SEBI PIT Regulation, 2015
Oct 2024
29 Oct · Announcement under Regulation 30 (LODR)-Allotment
29 Oct · Results
21 Oct · Board meeting
Meeting on 29 Oct 2024: quarterly results
Sep 2024
Aug 2024
31 Aug · Management
10 Aug · Management
8 Aug · Intimation Of Managment Discussion And Anaylsis Report For Quarter Ended On 30Th June, 2024
Jul 2024
31 Jul · Board meeting
Meeting on 8 Aug 2024: quarterly results
Jun 2024
12 Jun · Reg. 34 (1) Annual Report.
10 Jun · Board meeting
6 Jun · Board meeting
Meeting on 10 Jun 2024: annual general meeting and preferential issue of shares5 Jun · Announcement under Regulation 30 (LODR)-Allotment
May 2024
27 May · Board meeting
Meeting on 5 Jun 2024: annual general meeting23 May · Geanral Update About The Company As On 22Nd May 2024
10 May · Board meeting
Meeting on 22 May 2024: audited results and quarterly results9 May · GENERAL ANNOUNCEMENT AS PER SEBI LODR, 2015 UPDATE ABOUT COMPANY
Apr 2024
29 Apr · Board meeting